News

06/2017. EAACI 2017 Award

June 2017

The study presented at the EAACI 2017 (European Academy of Allergy and Clinical Immunology) (Helsinki, Finland) by Cristina Benito Villalvilla
More info

06/2017. Immunotherapy Seminars

June 2017

On June 2, has been started the Seminars on allergen-specific immunotherapy: From Leonard Noon to the new vaccines targeted to dendritic cells
More info

05/2017. FEBS-MPST 2017 Award

May 2017

The study presented by Dr. Ioanna Kalograiaki during the advanced course of the FEBS (Federation of European Biochemical Societies) Matrix Pathology, Signaling and Molecular Targets, has been awarded the best presentation
More info

05/2017. Madrid Capital del Progreso

May 2017

As INMUNOTEK has been included in the FT 1000 ranking of the Financial Times, our CEO, Dr. José Luis Subiza has been interviewed for a special monograph "Madrid Capital del Progreso" of the newspaper El Mundo, where he reviews the present, projects and challenges of the company
More info

04/2017. International Day of Immunology

April 2017

The International Day of Immunology is celebrated worldwide on 29 April with the aim of disseminating immunology among the general public and making this discipline known in its important role in health and disease
More info

03/2017. Mosquito Aedes aegypti

March 2017

Mosquito allergy is common in certain geographical areas but their allergens are still misidentified. It has been published in the journal Allergy and  Annals of Allergy, Asthma & Immunology two new studies on this topic
More info

01/2017. Basophils

January 2017

Basophils participate in allergic reactions and the absence of these receptors would avoid the risk of activation of these cells with mannan-conjugated vaccines (Sirvent et al-Manzano et al). These new vaccines have been designed by INMUNOTEK
More info

12/2016. UROMUNE Mechanisms

December 2016

The scientific journal Mucosal Immunology has published an article on the immunological mechanisms involved in the action of the polybacterial vaccine MV140 (UROMUNE).
More info

12/2016. CLUSTOID / CLUSTEK - Safety study

December 2016

A study of 1,855 patients (1,156 adults and 699 children) who have been treated with Clustoid / Clustek (INMUNOTEK), including the most allergenic concentrations (Max and Forte), has been published online in the journal Allergologia et Immunopathologia.
More info

11/2016. 7th SICAM Conference Awards

November 2016

Of all the scientific communications presented to the VII SICAM (Sociedad Inmunologia de la Comunidad de Madrid) Conference held last November 18 at the Instituto de Salud Carlos III, twelve were selected for the INMUNOTEK awards.
More info